| Jul 1, 2026 |
Fairmount Funds Management LLC |
ORKA Oruka Therapeutics, Inc. |
OTHER |
42,641 |
N/A |
| Jul 1, 2026 |
Fairmount Funds Management LLC |
ORKA Oruka Therapeutics, Inc. |
SELL |
3,553,410 |
$300.0M |
| Jul 1, 2026 |
Fairmount Funds Management LLC |
ORKA Oruka Therapeutics, Inc. |
OTHER |
3,553,410 |
N/A |
| Jun 23, 2026 |
Fairmount Funds Management LLC |
SYRE Spyre Therapeutics, Inc. |
OTHER |
16,667 |
N/A |
| Jun 23, 2026 |
Fairmount Funds Management LLC |
SYRE Spyre Therapeutics, Inc. |
SELL |
4,684,781 |
$399.7M |
| Jun 23, 2026 |
Fairmount Funds Management LLC |
SYRE Spyre Therapeutics, Inc. |
OTHER |
666,680 |
N/A |
| Jun 9, 2026 |
Fairmount Funds Management LLC |
APGE Apogee Therapeutics, Inc. |
OTHER |
7,657 |
N/A |
| Jun 9, 2026 |
Fairmount Funds Management LLC |
JBIO Jade Biosciences, Inc. |
OTHER |
34,843 |
N/A |
| Jun 2, 2026 |
Fairmount Funds Management LLC |
ORKA Oruka Therapeutics, Inc. |
OTHER |
9,136 |
N/A |
| Jun 2, 2026 |
Fairmount Funds Management LLC |
CBIO CRESCENT BIOPHARMA, INC. |
OTHER |
11,050 |
N/A |
| May 27, 2026 |
Fairmount Funds Management LLC |
SYRE Spyre Therapeutics, Inc. |
OTHER |
8,026 |
N/A |
| May 11, 2026 |
Fairmount Funds Management LLC |
VRDN Viridian Therapeutics, Inc.\DE |
BUY |
1,176,470 |
$20.0M |
| Mar 31, 2026 |
Fairmount Funds Management LLC |
ZBIO Zenas BioPharma, Inc. |
BUY |
150,000 |
$3.0M |
| Mar 31, 2026 |
Fairmount Funds Management LLC |
COGT Cogent Biosciences, Inc. |
OTHER |
28,000 |
N/A |
| Mar 31, 2026 |
Fairmount Funds Management LLC |
COGT Cogent Biosciences, Inc. |
SELL |
7,000,000 |
$242.6M |
| Mar 31, 2026 |
Fairmount Funds Management LLC |
COGT Cogent Biosciences, Inc. |
OTHER |
7,000,000 |
N/A |
| Mar 23, 2026 |
Fairmount Funds Management LLC |
DMRA Damora Therapeutics, Inc. |
OTHER |
37,313 |
N/A |
